Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma

Clinical trial NCT02427620 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02427620
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Blastoid Variant Mantle Cell Lymphoma Mantle Cell Lymphoma Pleomorphic Variant Mantle Cell Lymphoma

Start date: 2015-06-03
Primary completion: 2027-06-30
Enrollment: 131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.